Skip to main content

Align Technology to Award Research Programs Advancing Orthodontic and Dental Patient Care

2022 Grant Application Process Now Open for Up to $375,000 in Funding

TEMPE, Ariz., Nov. 02, 2021 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2022 Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $375,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology’s Research Award Program has funded approximately $2.4 million in research since the program’s inception in 2010.

“The research supported by Align has provided valuable insights into important areas of oral healthcare and assessment, including intraoral scanning and patient experience, quality of life changes, as well as insights into the biochemical markers of bone metabolism during early orthodontic tooth movement with clear aligners,” said John Morton, Align vice president, product innovation and Technical Fellow. “We are honored to receive applications across a broad spectrum of scientific topics that relate to dentistry, clear aligner treatment, and intraoral scanning.”

“Align is committed to providing opportunities for universities to conduct research to advance the study of dental science and orthodontic treatment,” said Dr. Mitra Derakhshan, Align vice president, global clinical. “We are impressed by the enthusiasm with which the Align Research Awards program is received by universities worldwide, as shown by the number of applications received and the diversity of research topics. In fact, we believe funding these research projects is so important to the advancement of dental and orthodontic treatment that we increased overall funding for the program.”

Awards available for dental research at universities are available in the following regions:

  • Americas (US, Canada, Mexico, Central and South America): Five one-year awards of up to US$25,000 each
  • EMEA: Five one-year awards of up to US$25,000 each
  • APAC: Five one-year awards of up to US$25,000 each

Eligible applicants for dental research awards include full- and part-time faculty involved in dental or scientific research at universities at which Invisalign® treatment or the iTero scanner is available. All applications are reviewed by an independent academic committee that forwards its recommendations to Align Technology for final selection. Program details, instructions, and application forms for prospective applicants can be found at https://learn.invisalign.com/research-awards-landing-page (for Americas, EMEA and APAC applicants). Research proposals and completed applications must be received by 5:00 p.m. Pacific Time on March 4, 2022. Award recipients will be notified by June 6, 2022.

About Align Technology, Inc.

Align Technology designs, manufactures and offers the Invisalign system, the most advanced clear aligner system in the world, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 210 thousand doctor customers and is key to accessing Align’s 500 million consumer market opportunity worldwide. Align has helped doctors treat over 11.6 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Align TechnologyZeno Group
Madelyn ValenteSarah Johnson
(408) 470-1180(828) 551-4201
mvalente@aligntech.comsarah.johnson@zenogroup.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.